Navigation Links
Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
Date:3/19/2008

and publish all-payer performance results. The value exchanges will also become part of a nationwide Learning Network through which they can share experiences, best practices, and identify areas where innovation is needed.

"Currently, we don't have a sense of how we are doing in terms of delivering high value health care in Oregon," said Ralph Prows, M.D., Senior Medical Director for Regence and Chairman of Oregon Health Care Quality Corporation. "A cooperative approach to measuring care value -- one that focuses on improvement -- is the only way this will work. All of us -- doctors, hospitals, health plans, purchasers, patients, government -- can and will do better with good information."

About Oregon Health Care Quality Corporation:

The Oregon Health Care Quality Corporation is a non-profit partnership that brings together physician groups, nurses, hospitals, health plans, purchasers, consumers and policy makers to improve the quality of health care through collaborative leadership. The group focuses on projects that measure and report care quality, align quality improvement assistance to providers, engage consumers in a quality health care system, and foster electronic exchange of health information.


'/>"/>
SOURCE Oregon Health Care Quality Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Phlo Affiliate Reports Expanded Coverage to Oregon Border
2. Assured Pharmacy Consolidates Portland, Oregon Pharmacy
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
10. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 The US markets on ... as the Dow Jones Industrial Average finished at 17,279.74, ... down 0.30%. The S&P 500 finished the session 0.05% ... of ten sectors finished on a positive note. The ... at 751.48, up 0.10%, with the index gaining 6.95% ...
(Date:9/22/2014)...  Spherix Incorporated (SPEX) -- an intellectual property development company ... announced that the United States Patent & Trademark Office (USPTO) ... of September that is part of a standard essential family ... , Application number: US 13/728,867 , Publication ... 2012 The listed inventors of the new ...
(Date:9/21/2014)... Chemical Sciences play a significant role in ... and safe water, healthy food, and dependable medicine ... scientists, educators, and scientists have a great role ... Chemistry for the national development, and to foster ... fastest emerging Sciences, accelerating with a tremendous speed ...
(Date:9/20/2014)... MediVet America and NanoFiber Veterinary ... at the specialized Wolvega Horse Clinic. , Due to ... was ruptured 90% and her deep digital flexor tendon ... sentence for a horse. , The clinic has performed ... This revolutionary regenerative option for ruptured tendons has ...
Breaking Biology Technology:Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 3
... VRML ) announced that on February 22, 2008 it ... indicated the Company is not in,compliance with Marketplace Rule ... $2,500,000 in stockholders, equity; (ii) $35,000,000 in market,value of ... continuing,operations for the most recently completed fiscal year or ...
... SAN DIEGO, Feb. 27 Arena Pharmaceuticals,Inc. (Nasdaq: ... quarter,and full year ended December 31, 2007., Total ... million,compared to $4.7 million in the fourth quarter of ... 2007 were $19.3 million, compared to $30.6,million in the ...
... Feb. 27 DARA BioSciences(TM),(Nasdaq: DARA ) announced ... Board of Directors. Mr. Cochrane was appointed to fill ... and Compensation Committees.,The appointment was effective February 21, 2008., ... Franco, Sr.,commented, "We are pleased that Haywood has joined ...
Cached Biology Technology:Vermillion Receives NASDAQ Notice of Non-Compliance 2Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 2Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 4Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 5Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 6Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 7Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 8Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 9Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 10Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 11DARA BioSciences, Inc. Announces Appointment of New Director to Board 2
(Date:9/22/2014)... you may be at greater risk for stress-related ... cancer, according to a new study by Brandeis ... can trigger biological responses similar to the effects ... inflammation is an important part of our body,s ... and life-threatening diseases. , In a recently ...
(Date:9/22/2014)... Sept. 22, 2014 NXT-ID, Inc. (NASDAQ: ... the growing mobile commerce market, issues the following corporate ... recent funding. Letter from the ... round of funding and joined the NASDAQ to support ... its other biometric and authentication products and services. This strategic ...
(Date:9/21/2014)... On the eve of United Nations General Assembly events ... of mothers, newborns and children, Grand Challenges Canada, funded ... in grants for 22 bold ideas to address this ... A program for Bangladeshi mothers working in garment ... thereby improving infant nutrition, reducing absenteeism due to child ...
Breaking Biology News(10 mins):Obesity and stress pack a double hit for health 2NXT-ID Issues Shareholder Corporate Update 2NXT-ID Issues Shareholder Corporate Update 3NXT-ID Issues Shareholder Corporate Update 4Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 2Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 3Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 4Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 5Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 6Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 7Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 8Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 9Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 10Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 11Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 12Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 13Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 14Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 15
... BLOOMINGTON, Ind. -- Extra genomes appear, on average, to offer ... key role in the origin of new species, say scientists ... week,s Proceedings of the National Academy of Sciences . ... acquisition of extra chromosome sets -- was a gateway to ...
... On Monday, August 17th at 1:30PM in Hensill Hall ... the AAAS in San Francisco will get to learn about ... brightest minds in the field. The symposium is called ... to the Public. (Online link: http://www.sou.edu/aaaspd/2009SANFRANCISCO/Symposia09.html#15 ). As ...
... Researchers at Oregon State University have discovered that the ... them far more susceptible to pesticides at some times of ... scientists said, it may be possible to tap into this ... most vulnerable to a specific pesticide, and use that information ...
Cached Biology News:Genome duplication responsible for more plant species than previously thought 2Genome duplication responsible for more plant species than previously thought 3Science communication to take the stage at annual AAAS meeting in San Francisco 2Biological clocks of insects could lead to more effective pest control 2Biological clocks of insects could lead to more effective pest control 3
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
Rabbit polyclonal to MA2 ( Abpromise for all tested applications). entrezGeneID: 10687 SwissProtID: Q9UL42...
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications)....
Biology Products: